Cinqair is made by Teva Pharmaceuticals in Frazer, Pennsylvania.
Asthma is a chronic disease that causes inflammation in the airways of the lungs. During an asthma attack, airways become narrow making it hard to breathe. Severe asthma attacks can lead to asthma-related hospitalizations because these attacks can be serious and even life-threatening.
Cinqair is administered once every four weeks via intravenous infusion by a health care professional in a clinical setting prepared to manage anaphylaxis. Cinqair is a humanized interleukin-5 antagonist monoclonal antibody produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells. Cinqair reduces severe asthma attacks by reducing the levels of blood eosinophils, a type of white blood cell that contributes to the development of asthma.
According to the Centers for Disease Control and Prevention, as of 2013, more than 22 million people in the U.S. have asthma, and there are more than 400,000 asthma-related hospitalizations each year.
Asthma is a chronic disease that causes inflammation in the airways of the lungs. During an asthma attack, airways become narrow making it hard to breathe. Severe asthma attacks can lead to asthma-related hospitalizations because these attacks can be serious and even life-threatening.
Cinqair is administered once every four weeks via intravenous infusion by a health care professional in a clinical setting prepared to manage anaphylaxis. Cinqair is a humanized interleukin-5 antagonist monoclonal antibody produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells. Cinqair reduces severe asthma attacks by reducing the levels of blood eosinophils, a type of white blood cell that contributes to the development of asthma.
According to the Centers for Disease Control and Prevention, as of 2013, more than 22 million people in the U.S. have asthma, and there are more than 400,000 asthma-related hospitalizations each year.
Cinqair/reslizumab Side effects
Cinqair can cause serious side effects including
The most common side effects in clinical trials for Cinqair included anaphylaxis, cancer, and muscle pain.
- Allergic (hypersensitivity) reactions
- Anaphylactic shock
The most common side effects in clinical trials for Cinqair included anaphylaxis, cancer, and muscle pain.
- Skin rash (hives)
- Swelling of your face, lips, mouth, or tongue
- Symptoms of low blood pressure (fainting, dizziness, light headache, confusion, fast heart beat)
- Itching
- Paleness
- Flushing
- Nausea or abdominal discomfort
- Breathing problems
Cinqair/reslizumab Prescribing Information
Cinqair is approved for patients who have a history of severe asthma attacks (exacerbation's) despite receiving their current asthma medicines.Cinqair/reslizumab Cost
This drug is administered by your healthcare practitioner (HCP), which usually means:
- It may comes under special items category.
- You cannot fill this prescription in a regular pharmacy. Your doctor, hospital, or clinic will provide this medication because of possible complications or other issues.
- This drug is likely to be covered under your medical benefit if you have insurance.
0 Comments
For comments please reply here.......